Tag: BCR

  • C R Bard Inc Valuation – March 2017 $BCR

    C R Bard Inc Valuation – March 2017 $BCR

    C R Bard Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the high PEmg and PB ratios.

  • C R Bard Inc Valuation – August 2016 $BCR

    C R Bard Inc Valuation – August 2016 $BCR

    C R Bard Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • C.R. Bard Inc Stock Valuation – February 2016 $BCR

    C.R. Bard Inc Stock Valuation – February 2016 $BCR

    C R Bard Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • C.R. Bard Inc. Valuation – November 2015 Update $BCR

    C.R. Bard Inc. Valuation – November 2015 Update $BCR

    C.R. Bard Inc. qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio and the high PEmg and PB ratios. The Enterprising Investor is only initially concerned with the level of debt relative to the net current assets.

  • C.R. Bard Inc. Analysis – August 2015 Update $BCR

    C.R. Bard Inc. Analysis – August 2015 Update $BCR

    C.R. Bard Inc. qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio and the high PEmg and PB ratios.

  • The Best Companies of the Medical Industry – June 2015

    The Best Companies of the Medical Industry – June 2015

    While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, this article will take a brief look at the best companies of the medical industry, selecting the most promising investment opportunities within the industry, and giving a broad look into the industry as a whole.

  • 47 Companies in the Spotlight This Week – 5/16/15

    47 Companies in the Spotlight This Week – 5/16/15

    We evaluated 47 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • C.R. Bard Inc. Quarterly Valuation – May 2015 $BCR

    C.R. Bard Inc. Quarterly Valuation – May 2015 $BCR

    C.R. Bard Inc. should satisfy the Enterprising Investor, but not the Defensive Investor. The Defensive Investor is concerned with the high PEmg and PB ratios, while the Enterprising Investor has no initial concerns.

  • C.R. Bard Inc. Quarterly Valuation – January 2015 $BCR

    C.R. Bard Inc. Quarterly Valuation – January 2015 $BCR

    C.R. Bard Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the high PEmg and PB ratios. Meanwhile the Enterprising Investor has no initial concerns with the company.

  • 13 Companies in the Spotlight This Week – 10/4/14

    13 Companies in the Spotlight This Week – 10/4/14

    We evaluated 17 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic […]